Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness

Abdominal Imaging

Volumn 40, Issue 2, 2015, Pages 327-332

  Rosenkrantz, Andrew B ^a   Obele, Chika ^a   Rusinek, Henry ^a   Balar, Arjun V ^b   Huang, William C ^a   Deng, Fang Ming ^a   Ream, Justin M ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder cancer; Diffusion weighted imaging; Histogram; MRI

Indexed keywords

AGED; BLADDER TUMOR; COMPUTER ASSISTED DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; TUMOR INVASION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 84930692387     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-014-0213-y     Document Type: Article

References (25)

1. American Cancer Society (2013) Cancer facts and figures 2013. Atlanta: American Cancer Society
2. Verma S, Rajesh A, Prasad SR, et al. (2012) Urinary bladder cancer: role of MR imaging. Radiographics 32(2):371–387. doi:10.1148/rg.322115125
3. Vikram R, Sandler CM, Ng CS (2009) Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. Am J Roentgenol 192(6):1481–1487. doi:10.2214/AJR.08.1318
4. Gschwend JE, Dahm P, Fair WR (2002) Disease specific survival as endpoint of outcome for bladder cancer patients following radical cystectomy. Eur Urol 41(4):440–448
5. Ghoneim MA, Abdel-Latif M, el-Mekresh M, et al. (2008) Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 180(1):121–127. doi:10.1016/j.juro.2008.03.024
6. Grossman HB, Natale RB, Tangen CM, et al. (2003) Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Engl J Med 349(9):859–866. doi:10.1056/NEJMoa022148
7. International Collaboration of T, Medical Research Council Advanced Bladder Cancer Working P, European Organisation for R, et al. (2011) International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial. J Clinical Oncol 29(16):2171–2177. doi:10.1200/JCO.2010.32.3139
8. Raj GV, Karavadia S, Schlomer B, et al. (2011) Contemporary use of perioperative cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer. Cancer 117(2):276–282. doi:10.1002/cncr.25429
9. Kobayashi S, Koga F, Yoshida S, et al. (2011) Diagnostic performance of diffusion-weighted magnetic resonance imaging in bladder cancer: potential utility of apparent diffusion coefficient values as a biomarker to predict clinical aggressiveness. Eur Radiol. doi:10.1007/s00330-011-2174-7
10. Funatsu H, Imamura A, Takano H, Ueda T, Uno T (2012) Can pretreatment ADC values predict recurrence of bladder cancer after transurethral resection? Eur J Radiol 81(11):3115–3119. doi:10.1016/j.ejrad.2012.06.009
11. Yoshida S, Kobayashi S, Koga F, et al. (2013) Apparent diffusion coefficient as a prognostic biomarker of upper urinary tract cancer: a preliminary report. Eur Radiol 23(8):2206–2214. doi:10.1007/s00330-013-2805-2
12. Rosenkrantz AB (2013) Histogram-based apparent diffusion coefficient analysis: an emerging tool for cervical cancer characterization? Am J Roentgenol 200(2):311–313. doi:10.2214/AJR.12.9926
13. Kyriazi S, Collins DJ, Messiou C, et al. (2011) Metastatic ovarian and primary peritoneal cancer: assessing chemotherapy response with diffusion-weighted MR imaging-value of histogram analysis of apparent diffusion coefficients. Radiology 261(1):182–192. doi:10.1148/radiol.11110577
14. Lista F, Andres G, Caceres F, et al. (2013) Evaluation of risk of muscle invasion, perivesical and/or lymph node affectation by diffusion-weighted magnetic nuclear resonance in the patient who is a candidate for radical cystectomy. Actas Urol Esp 37(7):419–424. doi:10.1016/j.acuro.2013.04.003
15. Donati OF, Mazaheri Y, Afaq A, et al. (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271(1):143–152. doi:10.1148/radiol.13130973
16. Wheeler D (2004) Advanced topics in statistical process control, 2nd edn. Knoxville: SPC Press
17. Rosenkrantz AB, Haghighi M, Horn J, et al. (2013) Utility of quantitative MRI metrics for assessment of stage and grade of urothelial carcinoma of the bladder: preliminary results. Am J Roentgenol 201(6):1254–1259. doi:10.2214/AJR.12.10348
18. Kobayashi S, Koga F, Kajino K, et al. (2014) Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging 39(1):172–178. doi:10.1002/jmri.24148
19. Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K (2005) Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 53(6):1432–1440. doi:10.1002/mrm.20508
20. Yoshida S, Koga F, Kobayashi S, et al. (2012) Role of diffusion-weighted magnetic resonance imaging in predicting sensitivity to chemoradiotherapy in muscle-invasive bladder cancer. Int J Radiat Oncol Biol Phys 83(1):e21–e27. doi:10.1016/j.ijrobp.2011.11.065
21. Rosenkrantz AB, Mussi TC, Spieler B, et al. (2012) High-grade bladder cancer: association of the apparent diffusion coefficient with metastatic disease: preliminary results. J Magn Reson Imaging 35(6):1478–1483. doi:10.1002/jmri.23590
22. Downey K, Riches SF, Morgan VA, et al. (2013) Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. Am J Roentgenol 200(2):314–320. doi:10.2214/AJR.12.9545
23. Kierans AS, Bennett GL, Mussi TC, et al. (2013) Characterization of malignancy of adnexal lesions using ADC entropy: comparison with mean ADC and qualitative DWI assessment. J Magn Reson Imaging 37(1):164–171. doi:10.1002/jmri.23794
24. Raj GV, Herr H, Serio AM, et al. (2007) Treatment paradigm shift may improve survival of patients with high risk superficial bladder cancer. J Urol 177(4):1283–1286 (discussion 1286). doi:10.1016/j.juro.2006.11.090
25. Knoedler JJ, Boorjian SA, Kim SP, et al. (2012) Does partial cystectomy compromise oncologic outcomes for patients with bladder cancer compared to radical cystectomy? A matched case-control analysis. J Urol 188(4):1115–1119. doi:10.1016/j.juro.2012.06.029